Adona Medical, a Campbell, CA-based pre-clinical stage medical technology company, raised $37.5M in Series B funding.
The round was led by Cormorant Asset Management and The Capital Partnership (TCP), with participation from Excelestar Ventures, AMED Ventures, PA MedTech VC Fund, and Shifamed angel investors.
The company intends to use the funds to complete product development and support further evaluation of the company’s next-generation heart failure management platform.
Led by CEO Brian Fahey, Adona is a pre-clinical stage medical technology company developing next-generation solutions for patients with advanced heart failure. It is a privately held portfolio company of Shifamed LLC.
FinSMEs
02/05/2022